Pica Eating Disorder Treatment Market

Pica is an eating disorder in which people eat nonnutritive substances which are not typically thought as food such as paper, cloth, soap, hair, wool, soil, chalk, string, talcum powder, gum, paint, metal, pebbles, charcoal, ash, clay, starch, or ice. This can lead to intoxication in children which may result in impairment of both mental and physical development. Pica eating disorder can occur in any age group. There is no such kind of laboratory tests for pica instead the diagnosis can be done clinically. Iron deficiency anemia and malnutrition are the most common cause of the pica. There are various pica eating disorder treatment options available by using dietary supplements, different therapies are also available like psychotic therapy, cognitive behavioral approaches, nutritional counselling etc. Diagnosis of pica can be accompanied by the test for anemia as pica can occur in people who are malnourished. A lead level should be check-in children who have eaten any paint or objects covered in paint for lead poisoning. Pica eating disorder can lead to surgical emergencies due to obstructions in the intestine and parasitosis. Pica eating disorder often occurs with the mental health disorders which are associated with impaired functioning and can be seen in pregnant women. The pica eating disorder treatment may vary from patient to patient and may have psychosocial, environmental and family guidance approaches. Iron deficiency can be treated by iron supplements.
Pica Eating Disorder Treatment Market contains market size and forecasts of Pica Eating Disorder Treatment in Global, including the following market information:
Global Pica Eating Disorder Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pica Eating Disorder Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dietary Supplements Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pica Eating Disorder Treatment include Novartis International AG, GlaxoSmithKline plc., Merck KGaA, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceutical, Torrent Pharmaceuticals Ltd., Micro Labs Limited, FDC Limited and Emcure Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pica Eating Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pica Eating Disorder Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pica Eating Disorder Treatment Market Segment Percentages, by Type, 2021 (%)
Dietary Supplements
Antipsychotic Drugs
Antidepressants
Mood Stabilizers
Global Pica Eating Disorder Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pica Eating Disorder Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
Global Pica Eating Disorder Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pica Eating Disorder Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pica Eating Disorder Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pica Eating Disorder Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis International AG
GlaxoSmithKline plc.
Merck KGaA
Sun Pharmaceutical Industries Limited
Glenmark Pharmaceutical
Torrent Pharmaceuticals Ltd.
Micro Labs Limited
FDC Limited
Emcure Pharmaceuticals
Mankind Pharma